Poseida Therapeutics, Inc.
PSTXDelisted Jan 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001661460
Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding Poseida Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 2 | 0 | −2 |
| Shares | 100.0K | 0 | −100.0K (−100.0%) |
| Value | $308.0K | $0 | −$308.0K (−100.0%) |
New holders (0)
Institutions that held Poseida Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
None.
Sold out (2)
Institutions that held Poseida Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| DekaBank Deutsche Girozentrale | 100,000 | $308.0K |
| IFP Advisors, Inc | 0 | $2 |